Patent details
EP3654964 Title: COMPOSITION COMPRISING ATROPINE AND A MIOTIC AGENT AND ITS USE IN THE TREATMENT OF MYOPIA
Basic Information
- Publication number:
- EP3654964
- PCT Application Number:
- US2018043059
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP188360747
- PCT Publication Number:
- WO2019018749
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- COMPOSITION COMPRISING ATROPINE AND A MIOTIC AGENT AND ITS USE IN THE TREATMENT OF MYOPIA
- French Title of Invention:
- COMPOSITION COMPRENANT DE L'ATROPINE ET UN AGENT MIOTIQUE ET SON UTILISATION DANS LE TRAITEMENT DE LA MYOPIE
- German Title of Invention:
- ZUSAMMENSETZUNG ENTHALTEND ATROPINE UND EINEN MIOTISCHEN MITTEL UND IHRE VERWENDUNG BEI DER BEHANDLUNG VON MYOPIE
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 23/05/2024
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 10/06/2024
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 24/04/2024
- Unitary Effect Registration Date:
- 10/06/2024
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 20/07/2018
- Grant date:
- 24/04/2024
- EP Publication Date:
- 27/05/2020
- PCT Publication Date:
- 24/01/2019
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 24/04/2024
- EP B1 Publication Date:
- 24/04/2024
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 20/07/2038
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 17/04/2024
- Name:
- Seinda Pharmaceutical Guangzhou Corporation
- Address:
- Guangzhou International Bio-Island Luoxuan 4 Road 9, Suite C401, Guangzhou, 510300, China (CN)
Inventor
1
- Name:
- OUYANG, Hui
- Address:
- United States (US)
2
- Name:
- QIU, Yong
- Address:
- United States (US)
Priority
- Priority Number:
- 201762535111 P
- Priority Date:
- 20/07/2017
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 31/32; A61K 31/4178; A61K 9/00; A61K 31/222; A61K 31/498; A61K 31/551; A61K 31/46; A61K 45/06; A61P 27/02; A61K 31/417;
Publication
European Patent Bulletin
1
- Issue number:
- 202417
- Publication date:
- 24/04/2024
- Description:
- Grant (B1)
2
- Issue number:
- 202426
- Publication date:
- 26/06/2024
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202428
- Publication date:
- 10/07/2024
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|